sellWeak10b5-1 plan
Stephen K. Brannan sold $1.6M of KRTX
Chief Medical Officer at Karuna Therapeutics, Inc.. 5,000 shares at an average of $318.34, traded Mar 8, 2024, filed Mar 11, 2024.
Warning score
10Value
$1.6M
5,000 shares
Holdings after
42,604
-11% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$1.6M at market
- +5Share of holdings soldSold 11% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-029406, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 8, 2024 | MOption exercise Common Stock10b5-1 | +2,500 | $5.45 | $14k | 42,604 | Mar 11, 2024 |
| Mar 8, 2024 | MOption exercise Common Stock10b5-1 | +3,209 | $131.64 | $422k | 45,813 | Mar 11, 2024 |
| Mar 8, 2024 | MOption exercise Common Stock10b5-1 | +1,791 | $111.97 | $201k | 47,604 | Mar 11, 2024 |
| Mar 8, 2024 | SOpen-market sale Common Stock10b5-1 | -4,900 | $318.33 | $1.6M | 42,704 | Mar 11, 2024 |
| Mar 8, 2024 | SOpen-market sale Common Stock10b5-1 | -100 | $318.96 | $32k | 42,604 | Mar 11, 2024 |
| Mar 8, 2024 | MOption exercise Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 4,677 | Mar 11, 2024 |
| Mar 8, 2024 | MOption exercise Option (right to buy)derivative10b5-1 | -3,209 | $0.00 | $0 | 12,837 | Mar 11, 2024 |
| Mar 8, 2024 | MOption exercise Option (right to buy)derivative10b5-1 | -1,791 | $0.00 | $0 | 37,813 | Mar 11, 2024 |
Related signals
Other insiders at Karuna Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 15Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $4.8M 15,000 shares | -28% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $2.0M 10,000 shares | -22% | |
| 8Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $889k 5,000 shares | -13% | |
| 23Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.0M 5,000 shares | -27% | |
| 38Weak | Karuna Therapeutics, Inc. | Andrew Craig Miller Chief Operating Officer | $3.4M 15,000 shares | -57% | |
| 47Moderate | Karuna Therapeutics, Inc. | Troy A. Ignelzi Chief Financial Officer | $3.7M 16,500 shares | -62% | |
| 35Weak | Karuna Therapeutics, Inc. | Andrew Craig Miller Chief Operating Officer | $3.4M 15,000 shares | -37% | |
| 30Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.1M 5,000 shares | -25% | |
| 35Weak | Karuna Therapeutics, Inc. | Andrew Craig Miller Chief Operating Officer | $3.4M 15,000 shares | -28% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.